Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan
- PMID: 36078980
- PMCID: PMC9457207
- DOI: 10.3390/jcm11175050
Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan
Abstract
Inflammatory bowel disease (IBD) is a chronic and relapsing disease that can be complicated by abscesses, fistulas, or strictures of the damaged bowel. Endoscopy or imaging studies are required to diagnose and monitor the treatment response or complications of the disease. Due to the low incidence of the disease in Taiwan, the pattern of radiation exposure from medical imaging has not been well studied previously. This retrospective study aimed to evaluate the pattern of radiation exposure in 134 Taiwanese IBD patients (45 CD and 89 UC) diagnosed and followed at Changhua Christian Hospital from January 2010 to December 2020. We reviewed the patient demographic data and radiation-containing image studies performed during the follow-up. The cumulative effective dose (CED) was calculated for each patient. During a median follow-up of 4 years, the median CED was higher for patients with CD (median CED 21.2, IQR 12.1−32.8) compared to patients with UC (median CED 2.1, IQR 0−5.6) (p < 0.001). In addition, the CD patients had a trend of a higher rate of cumulative ≥50 mSv compared with the UC patients (6.7% vs. 1.1%, p = 0.110). In conclusion, our study found a higher radiation exposure among CD patients compared to patients with UC, representing the complicated nature of the disease. Therefore, increasing the use of radiation-free medical imaging such as intestinal ultrasound or magnetic resonance imaging should be advocated in daily practice to decrease the risk of excessive radiation exposure in these patients.
Keywords: Crohn’s disease; imaging; inflammatory bowel disease; radiation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Cumulative Effective Dose from Medical Imaging in Inflammatory Bowel Disease.Diagnostics (Basel). 2021 Dec 18;11(12):2387. doi: 10.3390/diagnostics11122387. Diagnostics (Basel). 2021. PMID: 34943623 Free PMC article.
-
Radiation Exposure in Patients with Inflammatory Bowel Disease: a Fourteen-Year Review at a Tertiary Care Centre in Malaysia.Asian Pac J Cancer Prev. 2017 Apr 1;18(4):933-939. doi: 10.22034/APJCP.2017.18.4.933. Asian Pac J Cancer Prev. 2017. PMID: 28545190 Free PMC article.
-
Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001-2011.Scand J Gastroenterol. 2017 Mar;52(3):300-305. doi: 10.1080/00365521.2016.1252945. Epub 2016 Nov 10. Scand J Gastroenterol. 2017. PMID: 27832710
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
A comprehensive review and update on Crohn's disease.Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18. Dis Mon. 2018. PMID: 28826742 Review.
Cited by
-
Cumulative radiation exposure from multimodality recurrent imaging of CT, fluoroscopically guided intervention, and nuclear medicine.Eur Radiol. 2024 Jun;34(6):3719-3729. doi: 10.1007/s00330-023-10299-7. Epub 2023 Nov 13. Eur Radiol. 2024. PMID: 37957362
-
High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease.Sci Rep. 2024 Jun 18;14(1):14091. doi: 10.1038/s41598-024-64930-8. Sci Rep. 2024. PMID: 38890510 Free PMC article.
-
The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients.Prz Gastroenterol. 2024;16(4):416-422. doi: 10.5114/pg.2023.132932. Epub 2023 Nov 17. Prz Gastroenterol. 2024. PMID: 39810868 Free PMC article.
-
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023.Intest Res. 2024 Jul;22(3):250-285. doi: 10.5217/ir.2024.00060. Epub 2024 Jul 29. Intest Res. 2024. PMID: 39099218 Free PMC article.
References
-
- Euers L., Abughazaleh S., Glassner K., Gajula P., Jones-Pauley M., Ezeana C., Puppala M., Wang L., Wong S., Oglat A., et al. Risk Factors for and Frequency of CT Scans, Steroid Use, and Repeat Visits in Inflammatory Bowel Disease Patients Seen at a Single-Center Emergency Department: A Retrospective Cohort Study. J. Clin. Med. 2021;10:2679. doi: 10.3390/jcm10122679. - DOI - PMC - PubMed
-
- Alshammari M.T., Stevenson R., Abdul-Aema B., Zou G., Jairath V., Radford S., Marciani L., Moran G.W. Diagnostic Accuracy of Non-Invasive Imaging for Detection of Colonic Inflammation in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Diagnostics. 2021;11:1926. doi: 10.3390/diagnostics11101926. - DOI - PMC - PubMed
-
- Turner D., Ricciuto A., Lewis A., D’Amico F., Dhaliwal J., Griffiths A.M., Bettenworth D., Sandborn W.J., Sands B.E., Reinisch W., et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–1583. doi: 10.1053/j.gastro.2020.12.031. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources